In the coming truncated week, the markets are expected to consolidate further with stock-specific action due to global ...

Trading window for the designated persons of Marksans Pharma Limited will remain closed from 1st July, 2024 until 48 hours after announcement of Unaudited Financial Results for the quarter ended 30th ...

Q2 Results 2024: Majors like Bharti Airtel, Sun Pharma, Adani Power, Indian Oil, Ambuja Cements, Punjab National Bank, Federal Bank, Indraprastha Gas, Pfizer, and others are releasing their Q2 ...

Now, some of them are looking for alternatives as geopolitical tensions rise. Sun Pharma Q2 Results: Sun Pharma reported a 28% year-on-year rise in Q2FY25 net profit to ₹3,040.16 crore ...

Astellas Pharma (JP:4503) has released an update. Astellas Pharma has withdrawn its marketing application for avacincaptad pegol, a treatment for geographic atrophy linked to age-related macular ...

Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

ABUJA – THE Director General, African Centre for Supply Chain, ACSC, Dr Obiora Madu, Thursday, declared that supply chain services remain catalyst to the country’s pharma sector and others.

Belt Hold Bullish 1H 68 Oct 22, 2024 11:00PM ...

Lagos—Two pharmaceutical companies, CHI Pharmaceuticals, a member of the Tropical General Investment (TGI) Group, and EVA Pharma, a global healthcare solutions provider acting across over 70 ...

The P&L A/C page of Marksans Pharma Ltd. presents the key P&L A/c Ratios, its comparison with the sector peers and 5 years of Profit & Loss Account Statement.

Inspired by this, big pharma companies will now allocate 5-10% of their Companys revenues to R&D for future biotech startups, hoping it will also attract more global partners. Marksans Pharma has ...